Therapeutic effect of ursolic acid in experimental visceral leishmaniasis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://dx.doi.org/10.1016/j.ijpddr.2016.12.002 http://hdl.handle.net/11449/173906 |
Resumo: | Leishmaniasis is an important neglected tropical disease, affecting more than 12 million people worldwide. The available treatments are not well tolerated and present diverse side effects in patients, justifying the search for new therapeutic compounds. In the present study, the therapeutic potential and toxicity of ursolic acid (UA), isolated from the leaves of Baccharis uncinella C. DC. (Asteraceae), were evaluated in experimental visceral leishmaniasis. To evaluate the therapeutic potential of UA, hamsters infected with L. (L.) infantum were treated daily during 15 days with 1.0 or 2.0 mg UA/kg body weight, or with 5.0 mg amphotericin B/kg body weight by intraperitoneal route. Fifteen days after the last dose, the parasitism of the spleen and liver was stimated and the main histopathological alterations were recorded. The proliferation of splenic mononuclear cells was evaluated and IFN-γ, IL-4, and IL-10 gene expressions were analyzed in spleen fragments. The toxicity of UA and amphotericin B were evaluated in healthy golden hamsters by histological analysis and biochemical parameters. Animals treated with UA had less parasites in the spleen and liver when compared with the infected control group, and they also showed preservation of white and red pulps, which correlate with a high rate of proliferation of splenic mononuclear cells, IFN-γ mRNA and iNOS production. Moreover, animals treated with UA did not present alterations in the levels of AST, ALT, creatinine and urea. Taken together, these findings indicate that UA is an interesting natural compound that should be considered for the development of prototype drugs against visceral leishmaniasis. |
id |
UNSP_19628097bd6fff54cc3388a34af2e865 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/173906 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Therapeutic effect of ursolic acid in experimental visceral leishmaniasisLeishmania (Leishmania) infantumTherapeutic potentialToxicityUrsolic acidLeishmaniasis is an important neglected tropical disease, affecting more than 12 million people worldwide. The available treatments are not well tolerated and present diverse side effects in patients, justifying the search for new therapeutic compounds. In the present study, the therapeutic potential and toxicity of ursolic acid (UA), isolated from the leaves of Baccharis uncinella C. DC. (Asteraceae), were evaluated in experimental visceral leishmaniasis. To evaluate the therapeutic potential of UA, hamsters infected with L. (L.) infantum were treated daily during 15 days with 1.0 or 2.0 mg UA/kg body weight, or with 5.0 mg amphotericin B/kg body weight by intraperitoneal route. Fifteen days after the last dose, the parasitism of the spleen and liver was stimated and the main histopathological alterations were recorded. The proliferation of splenic mononuclear cells was evaluated and IFN-γ, IL-4, and IL-10 gene expressions were analyzed in spleen fragments. The toxicity of UA and amphotericin B were evaluated in healthy golden hamsters by histological analysis and biochemical parameters. Animals treated with UA had less parasites in the spleen and liver when compared with the infected control group, and they also showed preservation of white and red pulps, which correlate with a high rate of proliferation of splenic mononuclear cells, IFN-γ mRNA and iNOS production. Moreover, animals treated with UA did not present alterations in the levels of AST, ALT, creatinine and urea. Taken together, these findings indicate that UA is an interesting natural compound that should be considered for the development of prototype drugs against visceral leishmaniasis.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Laboratory of Pathology of Infectious Diseases (LIM50) Department of Pathology Medical School of São Paulo University, Av. Dr. Arnaldo, 455. Cerqueira CésarCenter of Natural Sciences and Humanities Federal University of ABCGlobal Health and Tropical Medicine Instituto de Higiene e Medicina Tropical (IHMT) Universidade Nova de Lisboa, Rua da Junqueira 100Departamento de Análises Clínicas e Toxicológicas Centro de Ciências da Saúde Universidade Federal do Rio Grande do Norte, Rua General Gustavo Cordeiro de Farias, 384São Paulo State University (Unesp) Institute of Biosciences São Vicente, Praça Infante Dom Henrique, s/nSão Paulo State University (Unesp) Institute of Biosciences São Vicente, Praça Infante Dom Henrique, s/nFAPESP: 2013/10133-8FAPESP: 2013/16297-2FAPESP: 2015/11936-2FAPESP: 2016/00468-0Universidade de São Paulo (USP)Federal University of ABCUniversidade Nova de LisboaUniversidade Federal do Rio Grande do NorteUniversidade Estadual Paulista (Unesp)Jesus, Jéssica A.Fragoso, Thais N.Yamamoto, Eduardo S.Laurenti, Márcia D.Silva, Marcelo S.Ferreira, Aurea F.Lago, João Henrique G.Gomes, Gabriela S.Passero, Luiz Felipe D. [UNESP]2018-12-11T17:08:17Z2018-12-11T17:08:17Z2017-04-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1-11application/pdfhttp://dx.doi.org/10.1016/j.ijpddr.2016.12.002International Journal for Parasitology: Drugs and Drug Resistance, v. 7, n. 1, p. 1-11, 2017.2211-3207http://hdl.handle.net/11449/17390610.1016/j.ijpddr.2016.12.0022-s2.0-850040929862-s2.0-85004092986.pdfScopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengInternational Journal for Parasitology: Drugs and Drug Resistance1,556info:eu-repo/semantics/openAccess2023-10-19T06:03:43Zoai:repositorio.unesp.br:11449/173906Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T15:17:17.800910Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Therapeutic effect of ursolic acid in experimental visceral leishmaniasis |
title |
Therapeutic effect of ursolic acid in experimental visceral leishmaniasis |
spellingShingle |
Therapeutic effect of ursolic acid in experimental visceral leishmaniasis Jesus, Jéssica A. Leishmania (Leishmania) infantum Therapeutic potential Toxicity Ursolic acid |
title_short |
Therapeutic effect of ursolic acid in experimental visceral leishmaniasis |
title_full |
Therapeutic effect of ursolic acid in experimental visceral leishmaniasis |
title_fullStr |
Therapeutic effect of ursolic acid in experimental visceral leishmaniasis |
title_full_unstemmed |
Therapeutic effect of ursolic acid in experimental visceral leishmaniasis |
title_sort |
Therapeutic effect of ursolic acid in experimental visceral leishmaniasis |
author |
Jesus, Jéssica A. |
author_facet |
Jesus, Jéssica A. Fragoso, Thais N. Yamamoto, Eduardo S. Laurenti, Márcia D. Silva, Marcelo S. Ferreira, Aurea F. Lago, João Henrique G. Gomes, Gabriela S. Passero, Luiz Felipe D. [UNESP] |
author_role |
author |
author2 |
Fragoso, Thais N. Yamamoto, Eduardo S. Laurenti, Márcia D. Silva, Marcelo S. Ferreira, Aurea F. Lago, João Henrique G. Gomes, Gabriela S. Passero, Luiz Felipe D. [UNESP] |
author2_role |
author author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade de São Paulo (USP) Federal University of ABC Universidade Nova de Lisboa Universidade Federal do Rio Grande do Norte Universidade Estadual Paulista (Unesp) |
dc.contributor.author.fl_str_mv |
Jesus, Jéssica A. Fragoso, Thais N. Yamamoto, Eduardo S. Laurenti, Márcia D. Silva, Marcelo S. Ferreira, Aurea F. Lago, João Henrique G. Gomes, Gabriela S. Passero, Luiz Felipe D. [UNESP] |
dc.subject.por.fl_str_mv |
Leishmania (Leishmania) infantum Therapeutic potential Toxicity Ursolic acid |
topic |
Leishmania (Leishmania) infantum Therapeutic potential Toxicity Ursolic acid |
description |
Leishmaniasis is an important neglected tropical disease, affecting more than 12 million people worldwide. The available treatments are not well tolerated and present diverse side effects in patients, justifying the search for new therapeutic compounds. In the present study, the therapeutic potential and toxicity of ursolic acid (UA), isolated from the leaves of Baccharis uncinella C. DC. (Asteraceae), were evaluated in experimental visceral leishmaniasis. To evaluate the therapeutic potential of UA, hamsters infected with L. (L.) infantum were treated daily during 15 days with 1.0 or 2.0 mg UA/kg body weight, or with 5.0 mg amphotericin B/kg body weight by intraperitoneal route. Fifteen days after the last dose, the parasitism of the spleen and liver was stimated and the main histopathological alterations were recorded. The proliferation of splenic mononuclear cells was evaluated and IFN-γ, IL-4, and IL-10 gene expressions were analyzed in spleen fragments. The toxicity of UA and amphotericin B were evaluated in healthy golden hamsters by histological analysis and biochemical parameters. Animals treated with UA had less parasites in the spleen and liver when compared with the infected control group, and they also showed preservation of white and red pulps, which correlate with a high rate of proliferation of splenic mononuclear cells, IFN-γ mRNA and iNOS production. Moreover, animals treated with UA did not present alterations in the levels of AST, ALT, creatinine and urea. Taken together, these findings indicate that UA is an interesting natural compound that should be considered for the development of prototype drugs against visceral leishmaniasis. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-04-01 2018-12-11T17:08:17Z 2018-12-11T17:08:17Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1016/j.ijpddr.2016.12.002 International Journal for Parasitology: Drugs and Drug Resistance, v. 7, n. 1, p. 1-11, 2017. 2211-3207 http://hdl.handle.net/11449/173906 10.1016/j.ijpddr.2016.12.002 2-s2.0-85004092986 2-s2.0-85004092986.pdf |
url |
http://dx.doi.org/10.1016/j.ijpddr.2016.12.002 http://hdl.handle.net/11449/173906 |
identifier_str_mv |
International Journal for Parasitology: Drugs and Drug Resistance, v. 7, n. 1, p. 1-11, 2017. 2211-3207 10.1016/j.ijpddr.2016.12.002 2-s2.0-85004092986 2-s2.0-85004092986.pdf |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
International Journal for Parasitology: Drugs and Drug Resistance 1,556 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
1-11 application/pdf |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
|
_version_ |
1808128493878247424 |